Bill
A 4325
New Jersey bill authorizes expedited procurement of medical supplies and therapeutics during emergencies, bypassing standard bidding to enable faster response but reducing competitive oversight.
Bill A 4325 authorizes New Jersey to procure medical countermeasures, products, and therapeutics outside standard procurement procedures, likely during public health emergencies. The bill streamlines the acquisition process for critical medical supplies and treatments when rapid response is needed. This appears designed to enable faster purchasing when traditional bidding and approval timelines would be too slow.
During health emergencies—whether pandemics, bioterrorism threats, or disease outbreaks—delays in acquiring medical supplies can cost lives. This bill would allow state officials to bypass lengthy procurement processes to quickly secure vaccines, antivirals, antidotes, and other countermeasures. However, it also concentrates purchasing power in executive hands with potentially reduced oversight.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
